CN Stock MarketDetailed Quotes

300391 Changjiang Pharmaceutical Group

Watchlist
  • 6.91
  • +0.07+1.02%
Market Closed Nov 27 15:00 CST
2.42BMarket Cap-3608P/E (TTM)

Changjiang Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-51.27%6.74M
-21.35%10.06M
-32.30%8.55M
-13.00%15.2M
47.42%13.83M
-91.87%12.79M
-93.73%12.63M
-83.77%17.47M
-91.93%9.38M
38.98%157.26M
Notes receivable and accounts receivable
-3.30%1.52B
24.41%1.52B
13.49%1.6B
14.72%1.64B
6.87%1.57B
-10.97%1.22B
-1.54%1.41B
3.32%1.43B
23.19%1.47B
12.45%1.37B
-Notes receivable
----
----
----
--100K
----
----
----
----
-96.26%80K
--30.69M
-Accounts receivable
-3.30%1.52B
24.41%1.52B
13.49%1.6B
14.71%1.64B
6.88%1.57B
-8.93%1.22B
-1.41%1.41B
3.70%1.43B
23.40%1.47B
9.93%1.34B
Other receivables (including interest and dividends)
4.01%73.94M
32.28%73.22M
550.29%259.18M
676.28%243.94M
47.00%71.09M
30.61%55.35M
-7.12%39.86M
-40.39%31.42M
-80.96%48.36M
-73.40%42.38M
-Other receivable
----
32.28%73.22M
----
----
----
30.61%55.35M
----
-40.39%31.42M
----
-73.40%42.38M
Contractual assets
-79.38%5.28M
-95.38%845.31K
-62.15%6.92M
-62.15%6.92M
39.73%25.59M
-0.18%18.28M
71.50%18.28M
71.50%18.28M
-89.95%18.31M
-91.97%18.31M
Advance payment
-28.19%126.69M
-68.48%126.37M
-38.62%145.42M
-6.10%120.76M
104.65%176.42M
10.70%400.97M
-8.80%236.93M
3.82%128.6M
-25.61%86.21M
104.07%362.2M
Inventories
-20.19%45.42M
-60.41%54.15M
-24.98%53.7M
-12.80%51.86M
-52.58%56.91M
-1.34%136.77M
-54.99%71.59M
-69.55%59.47M
-39.21%120.02M
-47.51%138.63M
Receivable financing
----
171.43%95K
----
32.28%238.11K
359.40%3.57M
-99.93%35K
-99.19%827.08K
-99.86%180K
-99.44%776.19K
-48.61%50.69M
Other current assets
-3.65%44.07M
-28.36%50.41M
-13.53%43.38M
-11.88%50.45M
-15.03%45.75M
38.87%70.36M
25.97%50.16M
1.42%57.25M
78.24%53.83M
78.10%50.67M
Total current assets
-7.27%1.82B
-4.23%1.84B
15.05%2.12B
22.22%2.13B
8.70%1.97B
-12.59%1.92B
-18.12%1.84B
-15.41%1.74B
-18.83%1.81B
-4.24%2.19B
Non Current assets
Fixed assets
----
-11.54%748.72M
----
----
----
-21.41%846.42M
----
-20.34%882.47M
----
99.06%1.08B
Constru in process
----
0.54%189.25M
----
----
----
7.25%188.23M
----
4.47%177.94M
----
-71.92%175.5M
Productive biological assets
----
----
----
-7.47%1.95M
-6.93%1.99M
-6.53%2.03M
-5.89%2.07M
-5.58%2.11M
-11.26%2.14M
-10.25%2.17M
Intangible assets
-2.67%97.2M
-2.70%97.83M
139.39%98.5M
137.60%99.18M
135.27%99.86M
78.46%100.54M
-32.28%41.15M
-33.39%41.74M
-33.70%42.45M
-14.51%56.34M
Goodwill
-66.32%208.63M
-66.32%208.63M
-65.05%236.07M
-65.05%236.07M
-11.72%619.51M
-11.72%619.51M
-3.75%675.43M
-3.75%675.43M
0.00%701.73M
0.00%701.73M
Long deferred expense
----
----
----
----
----
-98.46%189.46K
-97.86%270.86K
-97.30%360.29K
-96.76%441.69K
-11.20%12.27M
Deferred tax assets
-6.22%16.47M
-64.04%16.47M
-59.52%16.47M
-58.63%16.47M
-52.04%17.56M
40.14%45.79M
-39.47%40.68M
-39.89%39.8M
-39.71%36.61M
-43.36%32.67M
Usufruct assets
-17.28%6.1M
-38.24%6.45M
-32.33%8.78M
-23.57%11.77M
-59.26%7.37M
-51.14%10.44M
-45.09%12.98M
-41.14%15.39M
--18.09M
--21.38M
Other non current assets
-69.80%813.5K
86.07%5.01M
-51.96%813.5K
78.51%3.02M
-63.43%2.69M
-63.43%2.69M
-23.23%1.69M
-66.66%1.69M
-74.03%7.36M
-63.97%7.36M
Total non current assets
-28.64%1.27B
-29.93%1.27B
-28.16%1.31B
-28.30%1.32B
-4.65%1.78B
-12.97%1.82B
-14.08%1.82B
-14.78%1.84B
-9.14%1.86B
2.88%2.09B
Total assets
-17.41%3.09B
-16.74%3.11B
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
Liabilities
Current liabilities
Short term loan
-57.93%199.98M
-56.65%219.72M
-59.25%214.98M
-61.91%205.12M
-13.95%475.4M
-23.05%506.91M
-15.66%527.57M
8.71%538.5M
21.60%552.46M
33.58%658.73M
Notes payable and accounts payable
7.83%326.37M
11.96%326.97M
45.02%361.12M
79.66%358.51M
21.40%302.68M
-44.86%292.05M
-57.75%249.02M
-68.96%199.55M
-54.95%249.32M
-6.90%529.63M
-Notes payable
-97.75%432.61K
-96.46%1.49M
-57.76%2.8M
493.26%17.46M
255.38%19.26M
-64.05%42.21M
-94.82%6.62M
-97.23%2.94M
-95.27%5.42M
25.15%117.4M
-Accounts payable
15.00%325.94M
30.27%325.48M
47.82%358.33M
73.47%341.04M
16.20%283.42M
-39.39%249.84M
-47.47%242.4M
-63.35%196.61M
-44.43%243.9M
-13.23%412.22M
Contract liabilities
-57.57%14.44M
-47.54%13.74M
-31.47%13.57M
17.08%16.95M
80.11%34.02M
23.24%26.19M
42.41%19.81M
9.09%14.48M
-12.69%18.89M
35.00%21.25M
Salaries payable
-0.21%25.91M
13.17%26.6M
-0.76%22.11M
-10.86%18.52M
48.27%25.96M
9.90%23.5M
9.28%22.28M
-22.67%20.78M
-8.49%17.51M
-1.72%21.38M
Taxs payable
-8.24%124.79M
-5.88%124.96M
-5.95%124.88M
-3.59%127.46M
5.44%135.99M
2.10%132.77M
1.87%132.78M
6.26%132.2M
-8.98%128.98M
0.09%130.04M
Other payable (including interest and dividends)
39.03%1.03B
48.87%961.98M
71.94%1.12B
84.00%1.04B
79.11%742.57M
-18.12%646.19M
-13.28%650.13M
-26.49%567.45M
-56.25%414.59M
-19.28%789.22M
-Interest payable
--26.02M
--23.89M
--28.74M
--20.44M
----
----
----
----
----
----
-Other payable
----
45.17%938.09M
----
----
----
-18.12%646.19M
----
-26.49%567.45M
----
-19.25%789.22M
Non current liabilities due within one year
77.74%106.96M
57.79%106.96M
162.73%106.38M
53.21%108.03M
68.34%60.18M
118.36%67.78M
29.11%40.49M
124.96%70.51M
--35.75M
--31.04M
Other current liabilities
-87.94%538.08K
-82.20%538.08K
-71.55%553.15K
8.66%1.72M
239.87%4.46M
-62.33%3.02M
15.70%1.94M
-58.88%1.59M
-46.63%1.31M
333.39%8.03M
Total current liabilities
2.81%1.83B
4.89%1.78B
19.31%1.96B
21.71%1.88B
25.55%1.78B
-22.42%1.7B
-23.97%1.64B
-26.77%1.55B
-33.71%1.42B
-0.89%2.19B
Current liabilities
Long term loan
51.52%480.9M
62.19%510.9M
47.17%504.48M
54.76%518.89M
-13.05%317.39M
-21.25%315M
-6.88%342.79M
7.97%335.29M
8.96%365M
19.40%400M
Long term account payable
----
----
----
----
----
-99.65%4.27K
----
-99.55%538.33K
----
-98.95%1.23M
Estimate liabilities
-55.91%12.95M
174.26%11.04M
-83.19%676.45K
-83.19%676.45K
--29.38M
-68.55%4.03M
-69.70%4.03M
-65.28%4.03M
----
1.48%12.8M
Deferred tax liabilities
8.40%7.1M
5.66%7.1M
3.00%7.1M
0.00%7.1M
-11.66%6.55M
-12.68%6.72M
-15.77%6.9M
-18.42%7.1M
-19.79%7.42M
-21.36%7.7M
Long term deferred income
-2.66%15M
-3.17%15.08M
-3.67%15.16M
-4.15%15.24M
-4.11%15.41M
-31.23%15.57M
-32.10%15.74M
-32.94%15.9M
-33.84%16.07M
-8.97%22.64M
Lease liabilities
6.64%5.92M
6.84%5.96M
-69.95%6.25M
-8.68%5.45M
-73.60%5.56M
-74.09%5.58M
-2.46%20.79M
-71.75%5.97M
--21.04M
--21.52M
Other non current liabilities
723.87%650.31K
723.87%650.31K
638.09%650.31K
723.87%650.31K
--78.93K
--78.93K
--88.11K
--78.93K
----
----
Total non current liabilities
39.58%522.53M
58.72%550.73M
36.84%534.32M
48.55%548.01M
-29.10%374.36M
-25.52%346.98M
-29.47%390.48M
-25.51%368.92M
6.02%527.98M
-6.80%465.89M
Total liabilities
9.20%2.35B
14.02%2.33B
22.67%2.5B
26.88%2.43B
10.73%2.16B
-22.97%2.05B
-25.09%2.03B
-26.53%1.91B
-26.21%1.95B
-1.98%2.66B
Shareholders equity
Paid-in capital
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
Capital reserve funds
0.01%788.17M
0.01%788.17M
0.01%788.17M
0.01%788.17M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
0.00%790.05M
0.00%790.05M
Surplus reserve funds
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
-5.60%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
Retained profit
-142.13%-1.14B
-193.00%-1.11B
-166.26%-1.01B
-170.08%-961.75M
-54.54%-471.94M
-1.93%-380.31M
-18.32%-379.05M
-6.99%-356.09M
-7.07%-305.39M
-25.23%-373.09M
Other composite income
----
----
----
----
----
----
----
----
----
-5.01%-143.88K
Specific reserves
----
----
----
----
----
----
----
----
----
-42.51%555.95K
Shareholders equity without minority interests
-97.93%14.15M
-94.52%42.55M
-81.02%147.62M
-75.63%195.12M
-19.75%684.82M
-1.22%776.46M
-7.49%777.71M
-3.10%800.67M
-2.38%853.35M
-8.77%786.06M
Minority interests
-19.86%723.07M
-19.50%733.07M
-7.89%788.59M
-4.83%822.2M
3.49%902.24M
8.68%910.59M
4.58%856.09M
10.34%863.95M
13.71%871.79M
12.11%837.86M
Total shareholder equity
-53.55%737.22M
-54.03%775.62M
-42.70%936.2M
-38.89%1.02B
-8.00%1.59B
3.89%1.69B
-1.54%1.63B
3.44%1.66B
5.14%1.73B
0.93%1.62B
Total liabilityies and equity
-17.41%3.09B
-16.74%3.11B
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
China Audit Asia Pacific Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -51.27%6.74M-21.35%10.06M-32.30%8.55M-13.00%15.2M47.42%13.83M-91.87%12.79M-93.73%12.63M-83.77%17.47M-91.93%9.38M38.98%157.26M
Notes receivable and accounts receivable -3.30%1.52B24.41%1.52B13.49%1.6B14.72%1.64B6.87%1.57B-10.97%1.22B-1.54%1.41B3.32%1.43B23.19%1.47B12.45%1.37B
-Notes receivable --------------100K-----------------96.26%80K--30.69M
-Accounts receivable -3.30%1.52B24.41%1.52B13.49%1.6B14.71%1.64B6.88%1.57B-8.93%1.22B-1.41%1.41B3.70%1.43B23.40%1.47B9.93%1.34B
Other receivables (including interest and dividends) 4.01%73.94M32.28%73.22M550.29%259.18M676.28%243.94M47.00%71.09M30.61%55.35M-7.12%39.86M-40.39%31.42M-80.96%48.36M-73.40%42.38M
-Other receivable ----32.28%73.22M------------30.61%55.35M-----40.39%31.42M-----73.40%42.38M
Contractual assets -79.38%5.28M-95.38%845.31K-62.15%6.92M-62.15%6.92M39.73%25.59M-0.18%18.28M71.50%18.28M71.50%18.28M-89.95%18.31M-91.97%18.31M
Advance payment -28.19%126.69M-68.48%126.37M-38.62%145.42M-6.10%120.76M104.65%176.42M10.70%400.97M-8.80%236.93M3.82%128.6M-25.61%86.21M104.07%362.2M
Inventories -20.19%45.42M-60.41%54.15M-24.98%53.7M-12.80%51.86M-52.58%56.91M-1.34%136.77M-54.99%71.59M-69.55%59.47M-39.21%120.02M-47.51%138.63M
Receivable financing ----171.43%95K----32.28%238.11K359.40%3.57M-99.93%35K-99.19%827.08K-99.86%180K-99.44%776.19K-48.61%50.69M
Other current assets -3.65%44.07M-28.36%50.41M-13.53%43.38M-11.88%50.45M-15.03%45.75M38.87%70.36M25.97%50.16M1.42%57.25M78.24%53.83M78.10%50.67M
Total current assets -7.27%1.82B-4.23%1.84B15.05%2.12B22.22%2.13B8.70%1.97B-12.59%1.92B-18.12%1.84B-15.41%1.74B-18.83%1.81B-4.24%2.19B
Non Current assets
Fixed assets -----11.54%748.72M-------------21.41%846.42M-----20.34%882.47M----99.06%1.08B
Constru in process ----0.54%189.25M------------7.25%188.23M----4.47%177.94M-----71.92%175.5M
Productive biological assets -------------7.47%1.95M-6.93%1.99M-6.53%2.03M-5.89%2.07M-5.58%2.11M-11.26%2.14M-10.25%2.17M
Intangible assets -2.67%97.2M-2.70%97.83M139.39%98.5M137.60%99.18M135.27%99.86M78.46%100.54M-32.28%41.15M-33.39%41.74M-33.70%42.45M-14.51%56.34M
Goodwill -66.32%208.63M-66.32%208.63M-65.05%236.07M-65.05%236.07M-11.72%619.51M-11.72%619.51M-3.75%675.43M-3.75%675.43M0.00%701.73M0.00%701.73M
Long deferred expense ---------------------98.46%189.46K-97.86%270.86K-97.30%360.29K-96.76%441.69K-11.20%12.27M
Deferred tax assets -6.22%16.47M-64.04%16.47M-59.52%16.47M-58.63%16.47M-52.04%17.56M40.14%45.79M-39.47%40.68M-39.89%39.8M-39.71%36.61M-43.36%32.67M
Usufruct assets -17.28%6.1M-38.24%6.45M-32.33%8.78M-23.57%11.77M-59.26%7.37M-51.14%10.44M-45.09%12.98M-41.14%15.39M--18.09M--21.38M
Other non current assets -69.80%813.5K86.07%5.01M-51.96%813.5K78.51%3.02M-63.43%2.69M-63.43%2.69M-23.23%1.69M-66.66%1.69M-74.03%7.36M-63.97%7.36M
Total non current assets -28.64%1.27B-29.93%1.27B-28.16%1.31B-28.30%1.32B-4.65%1.78B-12.97%1.82B-14.08%1.82B-14.78%1.84B-9.14%1.86B2.88%2.09B
Total assets -17.41%3.09B-16.74%3.11B-6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B
Liabilities
Current liabilities
Short term loan -57.93%199.98M-56.65%219.72M-59.25%214.98M-61.91%205.12M-13.95%475.4M-23.05%506.91M-15.66%527.57M8.71%538.5M21.60%552.46M33.58%658.73M
Notes payable and accounts payable 7.83%326.37M11.96%326.97M45.02%361.12M79.66%358.51M21.40%302.68M-44.86%292.05M-57.75%249.02M-68.96%199.55M-54.95%249.32M-6.90%529.63M
-Notes payable -97.75%432.61K-96.46%1.49M-57.76%2.8M493.26%17.46M255.38%19.26M-64.05%42.21M-94.82%6.62M-97.23%2.94M-95.27%5.42M25.15%117.4M
-Accounts payable 15.00%325.94M30.27%325.48M47.82%358.33M73.47%341.04M16.20%283.42M-39.39%249.84M-47.47%242.4M-63.35%196.61M-44.43%243.9M-13.23%412.22M
Contract liabilities -57.57%14.44M-47.54%13.74M-31.47%13.57M17.08%16.95M80.11%34.02M23.24%26.19M42.41%19.81M9.09%14.48M-12.69%18.89M35.00%21.25M
Salaries payable -0.21%25.91M13.17%26.6M-0.76%22.11M-10.86%18.52M48.27%25.96M9.90%23.5M9.28%22.28M-22.67%20.78M-8.49%17.51M-1.72%21.38M
Taxs payable -8.24%124.79M-5.88%124.96M-5.95%124.88M-3.59%127.46M5.44%135.99M2.10%132.77M1.87%132.78M6.26%132.2M-8.98%128.98M0.09%130.04M
Other payable (including interest and dividends) 39.03%1.03B48.87%961.98M71.94%1.12B84.00%1.04B79.11%742.57M-18.12%646.19M-13.28%650.13M-26.49%567.45M-56.25%414.59M-19.28%789.22M
-Interest payable --26.02M--23.89M--28.74M--20.44M------------------------
-Other payable ----45.17%938.09M-------------18.12%646.19M-----26.49%567.45M-----19.25%789.22M
Non current liabilities due within one year 77.74%106.96M57.79%106.96M162.73%106.38M53.21%108.03M68.34%60.18M118.36%67.78M29.11%40.49M124.96%70.51M--35.75M--31.04M
Other current liabilities -87.94%538.08K-82.20%538.08K-71.55%553.15K8.66%1.72M239.87%4.46M-62.33%3.02M15.70%1.94M-58.88%1.59M-46.63%1.31M333.39%8.03M
Total current liabilities 2.81%1.83B4.89%1.78B19.31%1.96B21.71%1.88B25.55%1.78B-22.42%1.7B-23.97%1.64B-26.77%1.55B-33.71%1.42B-0.89%2.19B
Current liabilities
Long term loan 51.52%480.9M62.19%510.9M47.17%504.48M54.76%518.89M-13.05%317.39M-21.25%315M-6.88%342.79M7.97%335.29M8.96%365M19.40%400M
Long term account payable ---------------------99.65%4.27K-----99.55%538.33K-----98.95%1.23M
Estimate liabilities -55.91%12.95M174.26%11.04M-83.19%676.45K-83.19%676.45K--29.38M-68.55%4.03M-69.70%4.03M-65.28%4.03M----1.48%12.8M
Deferred tax liabilities 8.40%7.1M5.66%7.1M3.00%7.1M0.00%7.1M-11.66%6.55M-12.68%6.72M-15.77%6.9M-18.42%7.1M-19.79%7.42M-21.36%7.7M
Long term deferred income -2.66%15M-3.17%15.08M-3.67%15.16M-4.15%15.24M-4.11%15.41M-31.23%15.57M-32.10%15.74M-32.94%15.9M-33.84%16.07M-8.97%22.64M
Lease liabilities 6.64%5.92M6.84%5.96M-69.95%6.25M-8.68%5.45M-73.60%5.56M-74.09%5.58M-2.46%20.79M-71.75%5.97M--21.04M--21.52M
Other non current liabilities 723.87%650.31K723.87%650.31K638.09%650.31K723.87%650.31K--78.93K--78.93K--88.11K--78.93K--------
Total non current liabilities 39.58%522.53M58.72%550.73M36.84%534.32M48.55%548.01M-29.10%374.36M-25.52%346.98M-29.47%390.48M-25.51%368.92M6.02%527.98M-6.80%465.89M
Total liabilities 9.20%2.35B14.02%2.33B22.67%2.5B26.88%2.43B10.73%2.16B-22.97%2.05B-25.09%2.03B-26.53%1.91B-26.21%1.95B-1.98%2.66B
Shareholders equity
Paid-in capital 0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M
Capital reserve funds 0.01%788.17M0.01%788.17M0.01%788.17M0.01%788.17M-0.25%788.07M-0.25%788.07M-0.25%788.07M-0.25%788.07M0.00%790.05M0.00%790.05M
Surplus reserve funds 0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M-5.60%18.36M0.00%18.36M0.00%18.36M0.00%18.36M
Retained profit -142.13%-1.14B-193.00%-1.11B-166.26%-1.01B-170.08%-961.75M-54.54%-471.94M-1.93%-380.31M-18.32%-379.05M-6.99%-356.09M-7.07%-305.39M-25.23%-373.09M
Other composite income -------------------------------------5.01%-143.88K
Specific reserves -------------------------------------42.51%555.95K
Shareholders equity without minority interests -97.93%14.15M-94.52%42.55M-81.02%147.62M-75.63%195.12M-19.75%684.82M-1.22%776.46M-7.49%777.71M-3.10%800.67M-2.38%853.35M-8.77%786.06M
Minority interests -19.86%723.07M-19.50%733.07M-7.89%788.59M-4.83%822.2M3.49%902.24M8.68%910.59M4.58%856.09M10.34%863.95M13.71%871.79M12.11%837.86M
Total shareholder equity -53.55%737.22M-54.03%775.62M-42.70%936.2M-38.89%1.02B-8.00%1.59B3.89%1.69B-1.54%1.63B3.44%1.66B5.14%1.73B0.93%1.62B
Total liabilityies and equity -17.41%3.09B-16.74%3.11B-6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------China Audit Asia Pacific Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data